Table 1.
Patient data |
Pathology |
MVD (vessels per field) |
Contrast-enhanced digital mammography results |
||||||
---|---|---|---|---|---|---|---|---|---|
ID | Age (years) | Malignant/benign | Lesion type | BMVD | LMVD | Iodine uptake at t = 3 min (mg iodine/cm2) | Time–iodine curve | Contrast at t = 3 min (mg iodine/cm2) | Time–contrast curve |
1 | 68 | M | IDCn | 48.8 | 23.6 | 2.62 | 2 | 1.89 | 2 |
3 | 44 | B | BF | 17.8 | 7.6 | 0.55 | 5 | −0.85 | 4 |
4 | 62 | M | IDC | 49.8 | 28.4 | 1.06 | 2 | 1.25 | 2 |
5 | 40 | B | BF | 23.8 | 6.6 | 1.78 | 1 | 1.18 | 1 |
6 | 54 | M | IDC | 67.4 | 41.2 | 1.75 | 3 | 2.17 | 3 |
7 | 50 | B | BF | 21.2 | 11.0 | 5.68 | 2 | 3.65 | 2 |
8 | 47 | B | BA | 27.2 | 14.6 | 1.54 | 2 | 0.77 | 2 |
9 | 60 | M | IDC | 60.6 | 46.6 | −0.98 | 4 | −0.64 | 4 |
11 | 56 | M | IDC | 45.2 | 17.0 | 1.83 | 1 | 1.05 | 1 |
12 | 61 | M | DCIS | 46.0 | 26.2 | −0.84 | 4 | −0.44 | 5 |
14 | 62 | M | IDC | 55.6 | 34.6 | 0.95 | 3 | −0.40 | 5 |
15 | 45 | M | IDC | 43.6 | 33.8 | 0.44 | 5 | −0.44 | 5 |
18 | 39 | B | BF | 20.2 | 8.0 | 1.51 | 2 | 1.68 | 2 |
21 | 42 | B | BF | 22.6 | 9.8 | 0.30 | 5 | 0.54 | 5 |
23 | 36 | B | BF | 20.0 | 5.6 | 4.95 | 2 | 3.77 | 2 |
24 | 38 | M | IDCn | 63.2 | 40.4 | 3.51 | 2 | 1.98 | 3 |
25 | 63 | M | IDCn | 59.0 | 43.4 | 4.69 | 2 | 4.22 | 2 |
26 | 59 | M | IDC | 60.6 | 33.6 | 1.38 | 2 | 1.48 | 2 |
B, benign; BA, microglandular adenosis; BF, fibroadenoma; BMVD, blood MVD; DCIS, ductal carcinoma in situ; ID, identification; IDC, invasive ductal carcinoma; IDCn, IDC with necrosis; LMVD, lymph MVD; M, malignant.
Only information related to the 18 patients included in the study is shown; the listed patient identification corresponds to the enrolment sequence.